[{"start_date": "2025-04-01", "end_date": "2025-06-30", "filing_date": "2025-08-05", "acceptance_datetime": "2025-08-05T20:57:29Z", "timeframe": "quarterly", "fiscal_period": "Q2", "fiscal_year": "2025", "cik": "0001743881", "sic": "2834", "tickers": ["BBIO"], "company_name": "BridgeBio Pharma, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-25-103192", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-25-103192/files/bbio-20250630_htm.xml", "financials": {"cash_flow_statement": {"net_cash_flow_from_investing_activities_continuing": {"value": -13002000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_continuing": {"value": 208358000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_financing_activities": {"value": 302041000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow": {"value": 208358000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_operating_activities": {"value": -80681000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_financing_activities_continuing": {"value": 302041000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_operating_activities_continuing": {"value": -80681000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_investing_activities": {"value": -13002000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}}, "income_statement": {"nonoperating_income_loss": {"value": -47380000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "research_and_development": {"value": 111231000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "selling_general_and_administrative_expenses": {"value": 129154000.0, "unit": "USD", "label": "Selling, General, and Administrative Expenses", "order": 1010}, "basic_average_shares": {"value": 190517215.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "income_tax_expense_benefit": {"value": 2100000.0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "operating_expenses": {"value": 241190000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "revenues": {"value": 110565000.0, "unit": "USD", "label": "Revenues", "order": 100}, "basic_earnings_per_share": {"value": -0.95, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "benefits_costs_expenses": {"value": 292223000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": -1855000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "income_loss_from_continuing_operations_before_tax": {"value": -181658000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "diluted_earnings_per_share": {"value": -0.95, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "net_income_loss_available_to_common_stockholders_basic": {"value": -181903000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "income_loss_from_continuing_operations_after_tax": {"value": -183758000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "net_income_loss_attributable_to_parent": {"value": -181903000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "income_loss_before_equity_method_investments": {"value": -161469000.0, "unit": "USD", "label": "Income/Loss Before Equity Method Investments", "order": 1300}, "other_operating_expenses": {"value": 805000, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "operating_income_loss": {"value": -134278000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "net_income_loss": {"value": -183758000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "diluted_average_shares": {"value": 190517215.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "income_loss_from_equity_method_investments": {"value": -20189000.0, "unit": "USD", "label": "Income/Loss From Equity Method Investments", "order": 2100}, "costs_and_expenses": {"value": 244843000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "cost_of_revenue": {"value": 3653000.0, "unit": "USD", "label": "Cost Of Revenue", "order": 300}, "gross_profit": {"value": 106912000.0, "unit": "USD", "label": "Gross Profit", "order": 800}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}}, "balance_sheet": {"other_noncurrent_assets": {"value": 132293000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "noncurrent_assets": {"value": 167913000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "liabilities": {"value": 2858609000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "current_liabilities": {"value": 175854000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "other_current_assets": {"value": 894000000.0, "unit": "USD", "label": "Other Current Assets", "order": 250}, "accounts_payable": {"value": 26134000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "noncurrent_liabilities": {"value": 2682755000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "fixed_assets": {"value": 6107000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "current_assets": {"value": 912277000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "other_current_liabilities": {"value": 112533000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "equity": {"value": -1777974000.0, "unit": "USD", "label": "Equity", "order": 1400}, "intangible_assets": {"value": 29513000.0, "unit": "USD", "label": "Intangible Assets", "order": 330}, "inventory": {"value": 18277000.0, "unit": "USD", "label": "Inventory", "order": 230}, "liabilities_and_equity": {"value": 1080190000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "equity_attributable_to_noncontrolling_interest": {"value": 9886000.0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "equity_attributable_to_parent": {"value": -1787860000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "assets": {"value": 1080190000.0, "unit": "USD", "label": "Assets", "order": 100}, "wages": {"value": 37187000.0, "unit": "USD", "label": "Wages", "order": 730}}, "comprehensive_income": {"other_comprehensive_income_loss": {"value": 1000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_parent": {"value": -181902000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss": {"value": -183757000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": -1855000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}}}}, {"start_date": "2025-01-01", "end_date": "2025-03-31", "filing_date": "2025-04-29", "acceptance_datetime": "2025-04-29T21:05:17Z", "timeframe": "quarterly", "fiscal_period": "Q1", "fiscal_year": "2025", "cik": "0001743881", "sic": "2834", "tickers": ["BBIO"], "company_name": "BridgeBio Pharma, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-25-060314", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-25-060314/files/bbio-20250331_htm.xml", "financials": {"cash_flow_statement": {"net_cash_flow_from_investing_activities": {"value": -1595000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_investing_activities_continuing": {"value": -1595000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_financing_activities_continuing": {"value": 60328000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_operating_activities_continuing": {"value": -199235000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_operating_activities": {"value": -199235000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_continuing": {"value": -140502000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_financing_activities": {"value": 60328000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow": {"value": -140502000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}}, "income_statement": {"income_loss_from_equity_method_investments": {"value": -15556000.0, "unit": "USD", "label": "Income/Loss From Equity Method Investments", "order": 2100}, "diluted_average_shares": {"value": 190145253.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "basic_earnings_per_share": {"value": -0.88, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "income_loss_from_continuing_operations_before_tax": {"value": -169608000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "gross_profit": {"value": 113994000.0, "unit": "USD", "label": "Gross Profit", "order": 800}, "selling_general_and_administrative_expenses": {"value": 106365000.0, "unit": "USD", "label": "Selling, General, and Administrative Expenses", "order": 1010}, "operating_income_loss": {"value": -104372000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "basic_average_shares": {"value": 190145253.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "income_loss_before_equity_method_investments": {"value": -154052000.0, "unit": "USD", "label": "Income/Loss Before Equity Method Investments", "order": 1300}, "cost_of_revenue": {"value": 2639000.0, "unit": "USD", "label": "Cost Of Revenue", "order": 300}, "net_income_loss": {"value": -169608000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "income_loss_from_continuing_operations_after_tax": {"value": -169608000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "research_and_development": {"value": 111431000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "other_operating_expenses": {"value": 570000, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "operating_expenses": {"value": 218366000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "net_income_loss_attributable_to_parent": {"value": -167422000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "benefits_costs_expenses": {"value": 286241000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "net_income_loss_available_to_common_stockholders_basic": {"value": -167422000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "nonoperating_income_loss": {"value": -65236000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "income_tax_expense_benefit": {"value": 0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "revenues": {"value": 116633000.0, "unit": "USD", "label": "Revenues", "order": 100}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": -2186000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "costs_and_expenses": {"value": 221005000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "diluted_earnings_per_share": {"value": -0.88, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}}, "comprehensive_income": {"comprehensive_income_loss": {"value": -169616000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "other_comprehensive_income_loss": {"value": -8000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_parent": {"value": -167430000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": -2186000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}}, "balance_sheet": {"inventory": {"value": 3954000.0, "unit": "USD", "label": "Inventory", "order": 230}, "other_current_liabilities": {"value": 91133000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "liabilities": {"value": 2520303000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "intangible_assets": {"value": 27802000.0, "unit": "USD", "label": "Intangible Assets", "order": 330}, "liabilities_and_equity": {"value": 881638000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "noncurrent_assets": {"value": 186465000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "accounts_payable": {"value": 27525000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "equity_attributable_to_parent": {"value": -1648395000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "other_current_assets": {"value": 691219000.0, "unit": "USD", "label": "Other Current Assets", "order": 250}, "equity_attributable_to_noncontrolling_interest": {"value": 9957000.0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "assets": {"value": 881638000.0, "unit": "USD", "label": "Assets", "order": 100}, "other_noncurrent_assets": {"value": 151965000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "wages": {"value": 33447000.0, "unit": "USD", "label": "Wages", "order": 730}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "current_assets": {"value": 695173000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "equity": {"value": -1638438000.0, "unit": "USD", "label": "Equity", "order": 1400}, "current_liabilities": {"value": 152105000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "fixed_assets": {"value": 6698000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}}}}, {"start_date": "2024-10-01", "end_date": "2024-12-31", "timeframe": "quarterly", "fiscal_period": "Q4", "fiscal_year": "2024", "cik": "0001743881", "sic": "2834", "tickers": ["BBIO"], "company_name": "BridgeBio Pharma, Inc.", "financials": {"income_statement": {"income_loss_from_continuing_operations_after_tax": {"value": -267389000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "selling_general_and_administrative_expenses": {"value": 94782000.0, "unit": "USD", "label": "Selling, General, and Administrative Expenses", "order": 1010}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": -2339000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "net_income_loss_available_to_common_stockholders_basic": {"value": -265050000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "cost_of_revenue": {"value": 2084000.0, "unit": "USD", "label": "Cost Of Revenue", "order": 300}, "net_income_loss": {"value": -267389000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "basic_average_shares": {"value": 1128700.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "revenues": {"value": 5882000.0, "unit": "USD", "label": "Revenues", "order": 100}, "costs_and_expenses": {"value": 231909000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "operating_expenses": {"value": 229825000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "income_loss_from_equity_method_investments": {"value": -16695000.0, "unit": "USD", "label": "Income/Loss From Equity Method Investments", "order": 2100}, "basic_earnings_per_share": {"value": -1.42, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "income_tax_expense_benefit": {"value": 1153000.0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "net_income_loss_attributable_to_parent": {"value": -265050000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "income_loss_from_continuing_operations_before_tax": {"value": -266236000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "gross_profit": {"value": 3798000.0, "unit": "USD", "label": "Gross Profit", "order": 800}, "nonoperating_income_loss": {"value": -40209000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "other_operating_expenses": {"value": 4693000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "diluted_earnings_per_share": {"value": -1.42, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "income_loss_before_equity_method_investments": {"value": -249541000.0, "unit": "USD", "label": "Income/Loss Before Equity Method Investments", "order": 1300}, "diluted_average_shares": {"value": 1128700.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "operating_income_loss": {"value": -226027000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "benefits_costs_expenses": {"value": 272118000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "research_and_development": {"value": 130350000.0, "unit": "USD", "label": "Research and Development", "order": 1030}}, "balance_sheet": {"accounts_payable": {"value": 9618000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "wages": {"value": 58329000.0, "unit": "USD", "label": "Wages", "order": 730}, "liabilities": {"value": 2376950000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "intangible_assets": {"value": 23926000.0, "unit": "USD", "label": "Intangible Assets", "order": 330}, "equity": {"value": -1457754000.0, "unit": "USD", "label": "Equity", "order": 1400}, "fixed_assets": {"value": 7011000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "assets": {"value": 919338000.0, "unit": "USD", "label": "Assets", "order": 100}, "noncurrent_assets": {"value": 198646000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "current_assets": {"value": 720692000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "other_noncurrent_assets": {"value": 167709000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "noncurrent_liabilities": {"value": 2222550000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "liabilities_and_equity": {"value": 919338000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "current_liabilities": {"value": 154400000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "equity_attributable_to_parent": {"value": -1467904000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "equity_attributable_to_noncontrolling_interest": {"value": 10150000.0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "other_current_liabilities": {"value": 86453000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}}, "cash_flow_statement": {"net_cash_flow": {"value": 275368000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_investing_activities_continuing": {"value": -3237000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_financing_activities_continuing": {"value": 473931000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_continuing": {"value": 275368000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_financing_activities": {"value": 473931000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_operating_activities": {"value": -195326000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_operating_activities_continuing": {"value": -195326000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_investing_activities": {"value": -3237000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}}, "comprehensive_income": {"other_comprehensive_income_loss": {"value": 3000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": -2339000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss": {"value": -267386000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_parent": {"value": -265047000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}}}}, {"start_date": "2024-07-01", "end_date": "2024-09-30", "filing_date": "2024-11-12", "acceptance_datetime": "2024-11-12T12:32:57Z", "timeframe": "quarterly", "fiscal_period": "Q3", "fiscal_year": "2024", "cik": "0001743881", "sic": "2834", "tickers": ["BBIO"], "company_name": "BridgeBio Pharma, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-24-124577", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-24-124577/files/bbio-20240930_htm.xml", "financials": {"cash_flow_statement": {"net_cash_flow_from_financing_activities_continuing": {"value": 707000, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_financing_activities": {"value": 707000, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_continuing": {"value": -141633000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow": {"value": -141633000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_operating_activities": {"value": -180566000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_investing_activities": {"value": 38226000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_investing_activities_continuing": {"value": 38226000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_operating_activities_continuing": {"value": -180566000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}}, "income_statement": {"gross_profit": {"value": 2134000.0, "unit": "USD", "label": "Gross Profit", "order": 800}, "basic_earnings_per_share": {"value": -0.86, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "income_loss_from_continuing_operations_before_tax": {"value": -164254000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "net_income_loss": {"value": -164254000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": -2214000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "basic_average_shares": {"value": 188510372.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "income_tax_expense_benefit": {"value": 0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "income_loss_before_equity_method_investments": {"value": -157691000.0, "unit": "USD", "label": "Income/Loss Before Equity Method Investments", "order": 1300}, "other_operating_expenses": {"value": 4621000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "operating_expenses": {"value": 193884000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "net_income_loss_available_to_common_stockholders_basic": {"value": -162040000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "diluted_earnings_per_share": {"value": -0.86, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "operating_income_loss": {"value": -191750000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "research_and_development": {"value": 120444000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "benefits_costs_expenses": {"value": 166986000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "diluted_average_shares": {"value": 188510372.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "selling_general_and_administrative_expenses": {"value": 68819000.0, "unit": "USD", "label": "Selling, General, and Administrative Expenses", "order": 1010}, "nonoperating_income_loss": {"value": 27496000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "costs_and_expenses": {"value": 194482000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "cost_of_revenue": {"value": 598000, "unit": "USD", "label": "Cost Of Revenue", "order": 300}, "income_loss_from_equity_method_investments": {"value": -6563000.0, "unit": "USD", "label": "Income/Loss From Equity Method Investments", "order": 2100}, "revenues": {"value": 2732000.0, "unit": "USD", "label": "Revenues", "order": 100}, "income_loss_from_continuing_operations_after_tax": {"value": -164254000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "net_income_loss_attributable_to_parent": {"value": -162040000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}}, "comprehensive_income": {"comprehensive_income_loss": {"value": -164245000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_parent": {"value": -162031000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "other_comprehensive_income_loss": {"value": 9000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": -2214000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}}, "balance_sheet": {"accounts_payable": {"value": 13363000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "other_noncurrent_assets": {"value": 187173000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "liabilities": {"value": 1883369000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "current_liabilities": {"value": 139216000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "equity_attributable_to_parent": {"value": -1229922000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "equity": {"value": -1219037000.0, "unit": "USD", "label": "Equity", "order": 1400}, "current_assets": {"value": 444578000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "liabilities_and_equity": {"value": 664977000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "wages": {"value": 43541000.0, "unit": "USD", "label": "Wages", "order": 730}, "equity_attributable_to_noncontrolling_interest": {"value": 10885000.0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "noncurrent_liabilities": {"value": 1744153000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "fixed_assets": {"value": 8701000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "intangible_assets": {"value": 24525000.0, "unit": "USD", "label": "Intangible Assets", "order": 330}, "assets": {"value": 664977000.0, "unit": "USD", "label": "Assets", "order": 100}, "noncurrent_assets": {"value": 220399000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "other_current_liabilities": {"value": 82312000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}}}}, {"start_date": "2024-04-01", "end_date": "2024-06-30", "filing_date": "2024-08-01", "acceptance_datetime": "2024-08-01T20:24:46Z", "timeframe": "quarterly", "fiscal_period": "Q2", "fiscal_year": "2024", "cik": "0001743881", "sic": "2834", "tickers": ["BBIO"], "company_name": "BridgeBio Pharma, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-24-089326", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-24-089326/files/bbio-20240630_htm.xml", "financials": {"income_statement": {"income_tax_expense_benefit": {"value": 0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "nonoperating_income_loss": {"value": 99995000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "income_loss_from_continuing_operations_before_tax": {"value": -75544000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "income_loss_from_equity_method_investments": {"value": -7925000.0, "unit": "USD", "label": "Income/Loss From Equity Method Investments", "order": 2100}, "benefits_costs_expenses": {"value": 77712000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": -2088000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "basic_average_shares": {"value": 187586680.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "net_income_loss_available_to_common_stockholders_basic": {"value": -73456000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "cost_of_revenue": {"value": 598000, "unit": "USD", "label": "Cost Of Revenue", "order": 300}, "basic_earnings_per_share": {"value": -0.39, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "diluted_average_shares": {"value": 187586680.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "other_operating_expenses": {"value": 2891000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "net_income_loss": {"value": -75544000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "research_and_development": {"value": 114695000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "income_loss_before_equity_method_investments": {"value": -67619000.0, "unit": "USD", "label": "Income/Loss Before Equity Method Investments", "order": 1300}, "operating_income_loss": {"value": -175539000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "diluted_earnings_per_share": {"value": -0.39, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "costs_and_expenses": {"value": 177707000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "operating_expenses": {"value": 177109000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "selling_general_and_administrative_expenses": {"value": 59523000.0, "unit": "USD", "label": "Selling, General, and Administrative Expenses", "order": 1010}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "income_loss_from_continuing_operations_after_tax": {"value": -75544000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "gross_profit": {"value": 1570000.0, "unit": "USD", "label": "Gross Profit", "order": 800}, "net_income_loss_attributable_to_parent": {"value": -73456000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "interest_expense_operating": {"value": 22937000.0, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}, "revenues": {"value": 2168000.0, "unit": "USD", "label": "Revenues", "order": 100}}, "balance_sheet": {"assets": {"value": 794375000.0, "unit": "USD", "label": "Assets", "order": 100}, "other_current_liabilities": {"value": 87182000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "fixed_assets": {"value": 9840000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "equity": {"value": -1081870000.0, "unit": "USD", "label": "Equity", "order": 1400}, "noncurrent_assets": {"value": 178139000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "current_assets": {"value": 616236000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "intangible_assets": {"value": 25123000.0, "unit": "USD", "label": "Intangible Assets", "order": 330}, "current_liabilities": {"value": 134364000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "liabilities_and_equity": {"value": 794375000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "accounts_payable": {"value": 18126000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "liabilities": {"value": 1876468000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "other_noncurrent_assets": {"value": 143176000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "wages": {"value": 29056000.0, "unit": "USD", "label": "Wages", "order": 730}, "equity_attributable_to_noncontrolling_interest": {"value": 11055000.0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "equity_attributable_to_parent": {"value": -1092925000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_parent": {"value": -73462000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss": {"value": -75550000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": -2088000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "other_comprehensive_income_loss": {"value": -6000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}}, "cash_flow_statement": {"net_cash_flow_from_investing_activities": {"value": 3039000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_financing_activities_continuing": {"value": -5729000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_financing_activities": {"value": -5729000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_operating_activities_continuing": {"value": 74703000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow": {"value": 72013000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_operating_activities": {"value": 74703000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_investing_activities_continuing": {"value": 3039000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_continuing": {"value": 72013000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}}}}, {"start_date": "2024-01-01", "end_date": "2024-03-31", "filing_date": "2024-05-02", "acceptance_datetime": "2024-05-02T20:24:20Z", "timeframe": "quarterly", "fiscal_period": "Q1", "fiscal_year": "2024", "cik": "0001743881", "sic": "2834", "tickers": ["BBIO"], "company_name": "BridgeBio Pharma, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-24-052165", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-24-052165/files/bbio-20240331_htm.xml", "financials": {"balance_sheet": {"liabilities_and_equity": {"value": 849333000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "equity": {"value": -1037383000.0, "unit": "USD", "label": "Equity", "order": 1400}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "intangible_assets": {"value": 25721000.0, "unit": "USD", "label": "Intangible Assets", "order": 330}, "liabilities": {"value": 1886191000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "assets": {"value": 849333000.0, "unit": "USD", "label": "Assets", "order": 100}, "wages": {"value": 32395000.0, "unit": "USD", "label": "Wages", "order": 730}, "equity_attributable_to_parent": {"value": -1049528000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "noncurrent_assets": {"value": 65909000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "fixed_assets": {"value": 11414000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "other_current_liabilities": {"value": 104354000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "other_noncurrent_assets": {"value": 28774000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "accounts_payable": {"value": 4728000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "equity_attributable_to_noncontrolling_interest": {"value": 12145000.0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "current_assets": {"value": 783424000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "current_liabilities": {"value": 141477000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": -944000, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss_attributable_to_parent": {"value": -35245000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "other_comprehensive_income_loss": {"value": -29000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss": {"value": -36189000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}}, "income_statement": {"revenues": {"value": 211120000.0, "unit": "USD", "label": "Revenues", "order": 100}, "income_loss_from_continuing_operations_before_tax": {"value": -36160000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "operating_income_loss": {"value": 343000, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "interest_expense_operating": {"value": 23471000.0, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}, "income_tax_expense_benefit": {"value": 0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "net_income_loss_attributable_to_parent": {"value": -35216000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "gross_profit": {"value": 210522000.0, "unit": "USD", "label": "Gross Profit", "order": 800}, "basic_average_shares": {"value": 178705310.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "research_and_development": {"value": 140972000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "selling_general_and_administrative_expenses": {"value": 65807000.0, "unit": "USD", "label": "Selling, General, and Administrative Expenses", "order": 1010}, "costs_and_expenses": {"value": 210777000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "other_operating_expenses": {"value": 3400000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "income_loss_from_equity_method_investments": {"value": 0, "unit": "USD", "label": "Income/Loss From Equity Method Investments", "order": 2100}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "nonoperating_income_loss": {"value": -36503000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "operating_expenses": {"value": 210179000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "income_loss_from_continuing_operations_after_tax": {"value": -36160000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "cost_of_revenue": {"value": 598000, "unit": "USD", "label": "Cost Of Revenue", "order": 300}, "diluted_average_shares": {"value": 178705310.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "net_income_loss_available_to_common_stockholders_basic": {"value": -35216000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "diluted_earnings_per_share": {"value": -0.2, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "basic_earnings_per_share": {"value": -0.2, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "benefits_costs_expenses": {"value": 247280000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "income_loss_before_equity_method_investments": {"value": -36160000.0, "unit": "USD", "label": "Income/Loss Before Equity Method Investments", "order": 1300}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": -944000, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "net_income_loss": {"value": -36160000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}}, "cash_flow_statement": {"net_cash_flow_from_operating_activities_continuing": {"value": -219537000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow": {"value": 82764000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_investing_activities": {"value": 22753000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_investing_activities_continuing": {"value": 22753000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_financing_activities_continuing": {"value": 279548000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_operating_activities": {"value": -219537000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_continuing": {"value": 82764000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_financing_activities": {"value": 279548000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}}}}, {"start_date": "2023-10-01", "end_date": "2023-12-31", "timeframe": "quarterly", "fiscal_period": "Q4", "fiscal_year": "2023", "cik": "0001743881", "sic": "2834", "tickers": ["BBIO"], "company_name": "BridgeBio Pharma, Inc.", "financials": {"balance_sheet": {"equity_attributable_to_parent": {"value": -1354257000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "current_assets": {"value": 477593000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "other_noncurrent_assets": {"value": 30652000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "other_current_liabilities": {"value": 75819000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "liabilities_and_equity": {"value": 546380000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "fixed_assets": {"value": 11816000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "intangible_assets": {"value": 26319000.0, "unit": "USD", "label": "Intangible Assets", "order": 330}, "equity": {"value": -1343013000.0, "unit": "USD", "label": "Equity", "order": 1400}, "accounts_payable": {"value": 10655000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "assets": {"value": 546380000.0, "unit": "USD", "label": "Assets", "order": 100}, "wages": {"value": 57370000.0, "unit": "USD", "label": "Wages", "order": 730}, "noncurrent_assets": {"value": 68787000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "liabilities": {"value": 1888915000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "equity_attributable_to_noncontrolling_interest": {"value": 11244000.0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "noncurrent_liabilities": {"value": 1745071000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "current_liabilities": {"value": 143844000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}}, "cash_flow_statement": {"net_cash_flow_continuing": {"value": -129408000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_financing_activities_continuing": {"value": -4523000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_operating_activities": {"value": -124819000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_investing_activities": {"value": -66000, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_investing_activities_continuing": {"value": -66000, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow": {"value": -129408000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_financing_activities": {"value": -4523000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_operating_activities_continuing": {"value": -124819000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}}, "income_statement": {"income_loss_from_continuing_operations_after_tax": {"value": -170328000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "revenues": {"value": 1745000.0, "unit": "USD", "label": "Revenues", "order": 100}, "diluted_average_shares": {"value": 3900359.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": -2180000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "gross_profit": {"value": 1147000.0, "unit": "USD", "label": "Gross Profit", "order": 800}, "net_income_loss": {"value": -170328000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "basic_average_shares": {"value": 3900359.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "research_and_development": {"value": 130226000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "costs_and_expenses": {"value": 179161000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "nonoperating_income_loss": {"value": 7088000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "diluted_earnings_per_share": {"value": -0.96, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "other_operating_expenses": {"value": -3346000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "basic_earnings_per_share": {"value": -0.96, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "cost_of_revenue": {"value": 598000, "unit": "USD", "label": "Cost Of Revenue", "order": 300}, "net_income_loss_available_to_common_stockholders_basic": {"value": -168148000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "income_loss_from_continuing_operations_before_tax": {"value": -170328000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "net_income_loss_attributable_to_parent": {"value": -168148000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "operating_expenses": {"value": 178563000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "operating_income_loss": {"value": -177416000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "interest_expense_operating": {"value": 20268000.0, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}, "selling_general_and_administrative_expenses": {"value": 47583000.0, "unit": "USD", "label": "Selling, General, and Administrative Expenses", "order": 1010}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "benefits_costs_expenses": {"value": 172073000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_parent": {"value": -168151000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss": {"value": -170331000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": -2180000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "other_comprehensive_income_loss": {"value": -3000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}}}}, {"start_date": "2023-07-01", "end_date": "2023-09-30", "filing_date": "2023-11-02", "acceptance_datetime": "2023-11-02T20:23:01Z", "timeframe": "quarterly", "fiscal_period": "Q3", "fiscal_year": "2023", "cik": "0001743881", "sic": "2834", "tickers": ["BBIO"], "company_name": "BridgeBio Pharma, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-23-058255", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-23-058255/files/bbio-20230930_htm.xml", "financials": {"cash_flow_statement": {"net_cash_flow_from_operating_activities_continuing": {"value": -145226000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow": {"value": 199496000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_operating_activities": {"value": -145226000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_continuing": {"value": 199496000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_financing_activities_continuing": {"value": 307040000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_investing_activities_continuing": {"value": 37682000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_investing_activities": {"value": 37682000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_financing_activities": {"value": 307040000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}}, "comprehensive_income": {"other_comprehensive_income_loss": {"value": -29000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": -2489000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss_attributable_to_parent": {"value": -177028000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss": {"value": -179517000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}}, "balance_sheet": {"assets": {"value": 655008000.0, "unit": "USD", "label": "Assets", "order": 100}, "noncurrent_liabilities": {"value": 1742678000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "liabilities_and_equity": {"value": 655008000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "current_liabilities": {"value": 106065000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "equity_attributable_to_noncontrolling_interest": {"value": 12405000.0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "noncurrent_assets": {"value": 67338000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "accounts_payable": {"value": 4472000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "equity_attributable_to_parent": {"value": -1207543000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "other_noncurrent_assets": {"value": 28008000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "liabilities": {"value": 1848743000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "other_current_liabilities": {"value": 67858000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "wages": {"value": 33735000.0, "unit": "USD", "label": "Wages", "order": 730}, "equity": {"value": -1195138000.0, "unit": "USD", "label": "Equity", "order": 1400}, "intangible_assets": {"value": 26917000.0, "unit": "USD", "label": "Intangible Assets", "order": 330}, "fixed_assets": {"value": 12413000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "current_assets": {"value": 587670000.0, "unit": "USD", "label": "Current Assets", "order": 200}}, "income_statement": {"costs_and_expenses": {"value": 161783000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "selling_general_and_administrative_expenses": {"value": 35777000.0, "unit": "USD", "label": "Selling, General, and Administrative Expenses", "order": 1010}, "diluted_earnings_per_share": {"value": -1.08, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "operating_income_loss": {"value": -157692000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "income_loss_from_continuing_operations_before_tax": {"value": -179488000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "other_operating_expenses": {"value": 272000, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "income_tax_expense_benefit": {"value": 0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "revenues": {"value": 4091000.0, "unit": "USD", "label": "Revenues", "order": 100}, "diluted_average_shares": {"value": 163308632.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "nonoperating_income_loss": {"value": -21796000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "operating_expenses": {"value": 161185000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "interest_expense_operating": {"value": 20306000.0, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "research_and_development": {"value": 125136000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "net_income_loss": {"value": -179488000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "basic_average_shares": {"value": 163308632.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "net_income_loss_available_to_common_stockholders_basic": {"value": -176999000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "gross_profit": {"value": 3493000.0, "unit": "USD", "label": "Gross Profit", "order": 800}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": -2489000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "net_income_loss_attributable_to_parent": {"value": -176999000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "benefits_costs_expenses": {"value": 183579000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "income_loss_from_continuing_operations_after_tax": {"value": -179488000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "basic_earnings_per_share": {"value": -1.08, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "cost_of_revenue": {"value": 598000, "unit": "USD", "label": "Cost Of Revenue", "order": 300}}}}, {"start_date": "2023-04-01", "end_date": "2023-06-30", "filing_date": "2023-08-03", "acceptance_datetime": "2023-08-03T20:12:01Z", "timeframe": "quarterly", "fiscal_period": "Q2", "fiscal_year": "2023", "cik": "0001743881", "sic": "2834", "tickers": ["BBIO"], "company_name": "BridgeBio Pharma, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-23-037977", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-23-037977/files/bbio-20230630_htm.xml", "financials": {"income_statement": {"diluted_average_shares": {"value": 160535435.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": -2804000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "cost_of_revenue": {"value": 599000, "unit": "USD", "label": "Cost Of Revenue", "order": 300}, "income_loss_from_continuing_operations_after_tax": {"value": -160703000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "net_income_loss_attributable_to_parent": {"value": -157899000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "basic_earnings_per_share": {"value": -0.98, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "operating_expenses": {"value": 147141000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "operating_income_loss": {"value": -146099000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "gross_profit": {"value": 1042000.0, "unit": "USD", "label": "Gross Profit", "order": 800}, "costs_and_expenses": {"value": 147740000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "nonoperating_income_loss": {"value": -14604000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "selling_general_and_administrative_expenses": {"value": 36122000.0, "unit": "USD", "label": "Selling, General, and Administrative Expenses", "order": 1010}, "benefits_costs_expenses": {"value": 162344000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "net_income_loss_available_to_common_stockholders_basic": {"value": -157899000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "diluted_earnings_per_share": {"value": -0.98, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "income_tax_expense_benefit": {"value": 0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "revenues": {"value": 1641000.0, "unit": "USD", "label": "Revenues", "order": 100}, "research_and_development": {"value": 107488000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "income_loss_from_continuing_operations_before_tax": {"value": -160703000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "other_operating_expenses": {"value": 3531000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "interest_expense_operating": {"value": 20594000.0, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}, "basic_average_shares": {"value": 160535435.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "net_income_loss": {"value": -160703000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_parent": {"value": -157824000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss": {"value": -160628000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": -2804000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "other_comprehensive_income_loss": {"value": 75000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}}, "balance_sheet": {"wages": {"value": 28690000.0, "unit": "USD", "label": "Wages", "order": 730}, "other_noncurrent_assets": {"value": 30215000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "current_liabilities": {"value": 110120000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "intangible_assets": {"value": 27515000.0, "unit": "USD", "label": "Intangible Assets", "order": 330}, "current_assets": {"value": 432884000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "other_current_liabilities": {"value": 77556000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "liabilities_and_equity": {"value": 503661000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "equity": {"value": -1349971000.0, "unit": "USD", "label": "Equity", "order": 1400}, "fixed_assets": {"value": 13047000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "liabilities": {"value": 1853299000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "equity_attributable_to_parent": {"value": -1362023000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "equity_attributable_to_noncontrolling_interest": {"value": 12052000.0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "assets": {"value": 503661000.0, "unit": "USD", "label": "Assets", "order": 100}, "accounts_payable": {"value": 3874000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "noncurrent_assets": {"value": 70777000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}}, "cash_flow_statement": {"net_cash_flow_from_investing_activities": {"value": 4119000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_investing_activities_continuing": {"value": 4119000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_continuing": {"value": -110465000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_financing_activities_continuing": {"value": -1231000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_operating_activities_continuing": {"value": -113353000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_operating_activities": {"value": -113353000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow": {"value": -110465000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_financing_activities": {"value": -1231000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}}}}, {"start_date": "2023-01-01", "end_date": "2023-03-31", "filing_date": "2023-05-04", "acceptance_datetime": "2023-05-04T20:01:00Z", "timeframe": "quarterly", "fiscal_period": "Q1", "fiscal_year": "2023", "cik": "0001743881", "sic": "2834", "tickers": ["BBIO"], "company_name": "BridgeBio Pharma, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-23-017812", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-23-017812/files/bbio-20230331_htm.xml", "financials": {"comprehensive_income": {"comprehensive_income_loss_attributable_to_parent": {"value": -139840000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss": {"value": -142416000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": -2576000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "other_comprehensive_income_loss": {"value": 316000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}}, "income_statement": {"revenues": {"value": 1826000.0, "unit": "USD", "label": "Revenues", "order": 100}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "income_tax_expense_benefit": {"value": 0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "operating_expenses": {"value": 127989000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "gross_profit": {"value": 1175000.0, "unit": "USD", "label": "Gross Profit", "order": 800}, "cost_of_revenue": {"value": 651000, "unit": "USD", "label": "Cost Of Revenue", "order": 300}, "other_operating_expenses": {"value": 4020000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": -2576000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "diluted_earnings_per_share": {"value": -0.92, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "research_and_development": {"value": 92861000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "benefits_costs_expenses": {"value": 144558000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "net_income_loss_attributable_to_parent": {"value": -140156000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "operating_income_loss": {"value": -126163000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "diluted_average_shares": {"value": 152645635.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "basic_average_shares": {"value": 152645635.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "interest_expense_operating": {"value": 20121000.0, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}, "selling_general_and_administrative_expenses": {"value": 31108000.0, "unit": "USD", "label": "Selling, General, and Administrative Expenses", "order": 1010}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "income_loss_from_continuing_operations_after_tax": {"value": -142732000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "basic_earnings_per_share": {"value": -0.92, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "net_income_loss": {"value": -142732000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "income_loss_from_continuing_operations_before_tax": {"value": -142732000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "net_income_loss_available_to_common_stockholders_basic": {"value": -140156000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "nonoperating_income_loss": {"value": -16569000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "costs_and_expenses": {"value": 127989000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}}, "balance_sheet": {"noncurrent_assets": {"value": 72978000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "equity": {"value": -1213409000.0, "unit": "USD", "label": "Equity", "order": 1400}, "wages": {"value": 18869000.0, "unit": "USD", "label": "Wages", "order": 730}, "other_noncurrent_assets": {"value": 31299000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "other_current_liabilities": {"value": 73651000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "equity_attributable_to_noncontrolling_interest": {"value": 12256000.0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "accounts_payable": {"value": 4076000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "assets": {"value": 625680000.0, "unit": "USD", "label": "Assets", "order": 100}, "liabilities": {"value": 1839293000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "intangible_assets": {"value": 28113000.0, "unit": "USD", "label": "Intangible Assets", "order": 330}, "liabilities_and_equity": {"value": 625680000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "current_liabilities": {"value": 96596000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "equity_attributable_to_parent": {"value": -1225665000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "current_assets": {"value": 552702000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "fixed_assets": {"value": 13566000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}}, "cash_flow_statement": {"net_cash_flow_from_operating_activities": {"value": -144322000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_investing_activities": {"value": 12298000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_investing_activities_continuing": {"value": 12298000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_financing_activities_continuing": {"value": 150249000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_financing_activities": {"value": 150249000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow": {"value": 18225000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_operating_activities_continuing": {"value": -144322000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_continuing": {"value": 18225000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}}}}, {"start_date": "2022-10-01", "end_date": "2022-12-31", "timeframe": "quarterly", "fiscal_period": "Q4", "fiscal_year": "2022", "cik": "0001743881", "sic": "2834", "tickers": ["BBIO"], "company_name": "BridgeBio Pharma, Inc.", "financials": {"balance_sheet": {"other_noncurrent_assets": {"value": 30902000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "noncurrent_liabilities": {"value": 1746532000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "equity_attributable_to_parent": {"value": -1254617000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "liabilities": {"value": 1867960000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "noncurrent_assets": {"value": 74183000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "accounts_payable": {"value": 11558000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "equity": {"value": -1243335000.0, "unit": "USD", "label": "Equity", "order": 1400}, "current_liabilities": {"value": 121428000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "other_current_liabilities": {"value": 78614000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "fixed_assets": {"value": 14569000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "current_assets": {"value": 548853000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "assets": {"value": 623036000.0, "unit": "USD", "label": "Assets", "order": 100}, "equity_attributable_to_noncontrolling_interest": {"value": 11282000.0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "liabilities_and_equity": {"value": 623036000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "intangible_assets": {"value": 28712000.0, "unit": "USD", "label": "Intangible Assets", "order": 330}, "wages": {"value": 31256000.0, "unit": "USD", "label": "Wages", "order": 730}}, "income_statement": {"research_and_development": {"value": 90902000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "net_income_loss_attributable_to_parent": {"value": -137591000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "diluted_earnings_per_share": {"value": -0.9199999999999999, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "nonoperating_income_loss": {"value": -11338000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "selling_general_and_administrative_expenses": {"value": 31862000.0, "unit": "USD", "label": "Selling, General, and Administrative Expenses", "order": 1010}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": -2979000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "operating_income_loss": {"value": -129232000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "net_income_loss_available_to_common_stockholders_basic": {"value": -137591000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "net_income_loss": {"value": -140570000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "income_loss_from_continuing_operations_after_tax": {"value": -140570000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "revenues": {"value": 1870000.0, "unit": "USD", "label": "Revenues", "order": 100}, "diluted_average_shares": {"value": 630623, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "basic_earnings_per_share": {"value": -0.9199999999999999, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "basic_average_shares": {"value": 630623, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "benefits_costs_expenses": {"value": 142440000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "interest_expense_operating": {"value": 19990000.0, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}, "income_loss_from_continuing_operations_before_tax": {"value": -140570000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "other_operating_expenses": {"value": 4238000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "costs_and_expenses": {"value": 131102000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "operating_expenses": {"value": 131102000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}}, "cash_flow_statement": {"net_cash_flow_from_financing_activities": {"value": 6377000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_financing_activities_continuing": {"value": 6377000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_operating_activities_continuing": {"value": -93243000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow": {"value": -68901000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_investing_activities": {"value": 17965000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_continuing": {"value": -68901000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_operating_activities": {"value": -93243000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_investing_activities_continuing": {"value": 17965000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_parent": {"value": -137571000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": -2979000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss": {"value": -140550000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "other_comprehensive_income_loss": {"value": 20000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}}}}, {"start_date": "2022-07-01", "end_date": "2022-09-30", "filing_date": "2022-11-03", "timeframe": "quarterly", "fiscal_period": "Q3", "fiscal_year": "2022", "cik": "0001743881", "sic": "2834", "tickers": ["BBIO"], "company_name": "BridgeBio Pharma, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-22-021936", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-22-021936/files/bbio-20220930_htm.xml", "financials": {"balance_sheet": {"current_assets": {"value": 642219000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "fixed_assets": {"value": 15603000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "assets": {"value": 728740000.0, "unit": "USD", "label": "Assets", "order": 100}, "other_current_liabilities": {"value": 84194000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "noncurrent_liabilities": {"value": 1739919000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "other_noncurrent_assets": {"value": 41608000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "noncurrent_assets": {"value": 86521000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "accounts_payable": {"value": 10158000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "equity_attributable_to_noncontrolling_interest": {"value": 10432000.0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "liabilities_and_equity": {"value": 728740000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "wages": {"value": 24842000.0, "unit": "USD", "label": "Wages", "order": 730}, "current_liabilities": {"value": 119194000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "intangible_assets": {"value": 29310000.0, "unit": "USD", "label": "Intangible Assets", "order": 330}, "equity_attributable_to_parent": {"value": -1138417000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "equity": {"value": -1127985000.0, "unit": "USD", "label": "Equity", "order": 1400}, "liabilities": {"value": 1859113000.0, "unit": "USD", "label": "Liabilities", "order": 600}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": -2854000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss_attributable_to_parent": {"value": -137260000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss": {"value": -140114000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "other_comprehensive_income_loss": {"value": 79000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}}, "cash_flow_statement": {"net_cash_flow_from_financing_activities_continuing": {"value": 1445000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_operating_activities_continuing": {"value": -135163000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_investing_activities": {"value": 146857000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_continuing": {"value": 13139000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow": {"value": 13139000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_financing_activities": {"value": 1445000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_operating_activities": {"value": -135163000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_investing_activities_continuing": {"value": 146857000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}}, "income_statement": {"preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "costs_and_expenses": {"value": 129454000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "operating_income_loss": {"value": -129116000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "basic_earnings_per_share": {"value": -0.93, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "other_operating_expenses": {"value": 5755000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "income_tax_expense_benefit": {"value": 0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "selling_general_and_administrative_expenses": {"value": 31188000.0, "unit": "USD", "label": "Selling, General, and Administrative Expenses", "order": 1010}, "diluted_average_shares": {"value": 147937817.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "income_loss_from_continuing_operations_after_tax": {"value": -140193000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "interest_expense_operating": {"value": 19825000.0, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}, "net_income_loss": {"value": -140193000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": -2854000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "basic_average_shares": {"value": 147937817.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "operating_expenses": {"value": 129454000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "diluted_earnings_per_share": {"value": -0.93, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "income_loss_from_continuing_operations_before_tax": {"value": -140193000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "revenues": {"value": 338000, "unit": "USD", "label": "Revenues", "order": 100}, "net_income_loss_attributable_to_parent": {"value": -137339000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "nonoperating_income_loss": {"value": -11077000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "research_and_development": {"value": 92511000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "benefits_costs_expenses": {"value": 140531000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "net_income_loss_available_to_common_stockholders_basic": {"value": -137339000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}}}}, {"start_date": "2022-04-01", "end_date": "2022-06-30", "filing_date": "2022-08-04", "timeframe": "quarterly", "fiscal_period": "Q2", "fiscal_year": "2022", "cik": "0001743881", "sic": "2834", "tickers": ["BBIO"], "company_name": "BridgeBio Pharma, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-22-014824", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-22-014824/files/bbio-20220630_htm.xml", "financials": {"comprehensive_income": {"comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 7297000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss": {"value": -2603000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_parent": {"value": -9900000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "other_comprehensive_income_loss": {"value": -44000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}}, "cash_flow_statement": {"net_cash_flow_from_operating_activities_continuing": {"value": -30453000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_financing_activities": {"value": -20796000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_financing_activities_continuing": {"value": -20796000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_continuing": {"value": 98453000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_investing_activities_continuing": {"value": 149702000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_operating_activities": {"value": -30453000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow": {"value": 98453000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_investing_activities": {"value": 149702000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}}, "income_statement": {"net_income_loss_attributable_to_parent": {"value": -9856000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "basic_earnings_per_share": {"value": -0.07, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "interest_expense_operating": {"value": 20279000.0, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 7297000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "basic_average_shares": {"value": 146684804.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "nonoperating_income_loss": {"value": 77617000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "income_loss_from_continuing_operations_after_tax": {"value": -2559000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "revenues": {"value": 73746000.0, "unit": "USD", "label": "Revenues", "order": 100}, "costs_and_expenses": {"value": 153922000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "operating_income_loss": {"value": -80176000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "benefits_costs_expenses": {"value": 76305000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "diluted_earnings_per_share": {"value": -0.07, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "net_income_loss_available_to_common_stockholders_basic": {"value": -9856000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "research_and_development": {"value": 108400000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "income_tax_expense_benefit": {"value": 0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "selling_general_and_administrative_expenses": {"value": 36426000.0, "unit": "USD", "label": "Selling, General, and Administrative Expenses", "order": 1010}, "net_income_loss": {"value": -2559000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "income_loss_from_continuing_operations_before_tax": {"value": -2559000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "other_operating_expenses": {"value": 9096000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "diluted_average_shares": {"value": 146684804.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "operating_expenses": {"value": 153922000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}}, "balance_sheet": {"fixed_assets": {"value": 16873000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "accounts_payable": {"value": 8793000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "noncurrent_assets": {"value": 90953000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "liabilities": {"value": 1877246000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "equity_attributable_to_parent": {"value": -1025532000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "liabilities_and_equity": {"value": 862233000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "intangible_assets": {"value": 29908000.0, "unit": "USD", "label": "Intangible Assets", "order": 330}, "other_current_liabilities": {"value": 99758000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "other_noncurrent_assets": {"value": 44172000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "current_liabilities": {"value": 141160000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "equity": {"value": -1013514000.0, "unit": "USD", "label": "Equity", "order": 1400}, "assets": {"value": 862233000.0, "unit": "USD", "label": "Assets", "order": 100}, "wages": {"value": 32609000.0, "unit": "USD", "label": "Wages", "order": 730}, "equity_attributable_to_noncontrolling_interest": {"value": 12018000.0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "current_assets": {"value": 771280000.0, "unit": "USD", "label": "Current Assets", "order": 200}}}}, {"start_date": "2022-01-01", "end_date": "2022-03-31", "filing_date": "2022-05-05", "timeframe": "quarterly", "fiscal_period": "Q1", "fiscal_year": "2022", "cik": "0001743881", "sic": "2834", "tickers": ["BBIO"], "company_name": "BridgeBio Pharma, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-22-007874", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-22-007874/files/bbio-20220331_htm.xml", "financials": {"balance_sheet": {"noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "current_assets": {"value": 716230000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "assets": {"value": 813149000.0, "unit": "USD", "label": "Assets", "order": 100}, "noncurrent_assets": {"value": 96919000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "accounts_payable": {"value": 10107000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "other_noncurrent_assets": {"value": 49261000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "intangible_assets": {"value": 30476000.0, "unit": "USD", "label": "Intangible Assets", "order": 330}, "liabilities_and_equity": {"value": 813149000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "equity": {"value": -1041023000.0, "unit": "USD", "label": "Equity", "order": 1400}, "fixed_assets": {"value": 17182000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "equity_attributable_to_noncontrolling_interest": {"value": -27000, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "other_current_liabilities": {"value": 77898000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "liabilities": {"value": 1853836000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "equity_attributable_to_parent": {"value": -1040996000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "current_liabilities": {"value": 103463000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "wages": {"value": 15458000.0, "unit": "USD", "label": "Wages", "order": 730}, "temporary_equity": {"value": 336000, "unit": "USD", "label": "Temporary Equity", "order": 1700}}, "cash_flow_statement": {"net_cash_flow_from_operating_activities_continuing": {"value": -160635000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_investing_activities": {"value": 138623000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_investing_activities_continuing": {"value": 138623000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_financing_activities": {"value": -160000, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_financing_activities_continuing": {"value": -160000, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_operating_activities": {"value": -160635000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow": {"value": -22172000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_continuing": {"value": -22172000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}}, "comprehensive_income": {"other_comprehensive_income_loss": {"value": -251000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": -4933000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss": {"value": -201581000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_parent": {"value": -196648000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}}, "income_statement": {"preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "basic_earnings_per_share": {"value": -1.3399999999999999, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "diluted_earnings_per_share": {"value": -1.3399999999999999, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "net_income_loss_available_to_common_stockholders_basic": {"value": -196397000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "net_income_loss": {"value": -201330000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "net_income_loss_attributable_to_parent": {"value": -196397000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "benefits_costs_expenses": {"value": 203024000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "operating_expenses": {"value": 175372000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "selling_general_and_administrative_expenses": {"value": 43713000.0, "unit": "USD", "label": "Selling, General, and Administrative Expenses", "order": 1010}, "research_and_development": {"value": 107649000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "interest_expense_operating": {"value": 20344000.0, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "income_tax_expense_benefit": {"value": 0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "other_operating_expenses": {"value": 24010000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "nonoperating_income_loss": {"value": -27652000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "basic_average_shares": {"value": -399110, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "operating_income_loss": {"value": -173678000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "revenues": {"value": 1694000.0, "unit": "USD", "label": "Revenues", "order": 100}, "diluted_average_shares": {"value": -399110, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "income_loss_from_continuing_operations_after_tax": {"value": -201330000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "costs_and_expenses": {"value": 175372000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "income_loss_from_continuing_operations_before_tax": {"value": -201330000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": -4933000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}}}}, {"start_date": "2021-10-01", "end_date": "2021-12-31", "timeframe": "quarterly", "fiscal_period": "Q4", "fiscal_year": "2021", "cik": "0001743881", "sic": "2834", "tickers": ["BBIO"], "company_name": "BridgeBio Pharma, Inc.", "financials": {"comprehensive_income": {"comprehensive_income_loss": {"value": -152433000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "other_comprehensive_income_loss": {"value": -151000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": -5105000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss_attributable_to_parent": {"value": -147328000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}}, "balance_sheet": {"liabilities": {"value": 1878371000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "current_assets": {"value": 888858000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "wages": {"value": 37041000.0, "unit": "USD", "label": "Wages", "order": 730}, "noncurrent_assets": {"value": 123934000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "equity_attributable_to_noncontrolling_interest": {"value": 3412000.0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "equity": {"value": -867002000.0, "unit": "USD", "label": "Equity", "order": 1400}, "other_noncurrent_assets": {"value": 48934000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "intangible_assets": {"value": 44934000.0, "unit": "USD", "label": "Intangible Assets", "order": 330}, "current_liabilities": {"value": 135069000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "accounts_payable": {"value": 11884000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "equity_attributable_to_parent": {"value": -870414000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "noncurrent_liabilities": {"value": 1743302000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "assets": {"value": 1012792000.0, "unit": "USD", "label": "Assets", "order": 100}, "fixed_assets": {"value": 30066000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "liabilities_and_equity": {"value": 1012792000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "temporary_equity": {"value": 1423000.0, "unit": "USD", "label": "Temporary Equity", "order": 1700}, "other_current_liabilities": {"value": 86144000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}}, "income_statement": {"net_income_loss_attributable_to_noncontrolling_interest": {"value": -5105000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "income_loss_from_continuing_operations_before_tax": {"value": -152282000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "costs_and_expenses": {"value": 178500000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "net_income_loss_attributable_to_parent": {"value": -147177000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "net_income_loss": {"value": -152282000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "operating_expenses": {"value": 177328000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "revenues": {"value": 12886000.0, "unit": "USD", "label": "Revenues", "order": 100}, "operating_income_loss": {"value": -165614000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "benefits_costs_expenses": {"value": 165168000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "income_loss_from_continuing_operations_after_tax": {"value": -152282000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "cost_of_revenue": {"value": 1172000.0, "unit": "USD", "label": "Cost Of Revenue", "order": 300}, "research_and_development": {"value": 122200000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "nonoperating_income_loss": {"value": 13332000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "net_income_loss_available_to_common_stockholders_basic": {"value": -147177000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "selling_general_and_administrative_expenses": {"value": 54749000.0, "unit": "USD", "label": "Selling, General, and Administrative Expenses", "order": 1010}, "gross_profit": {"value": 11714000.0, "unit": "USD", "label": "Gross Profit", "order": 800}, "interest_expense_operating": {"value": 15134000.0, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}}, "cash_flow_statement": {"net_cash_flow_from_financing_activities": {"value": 325381000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_continuing": {"value": 213286000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_operating_activities": {"value": -133895000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_operating_activities_continuing": {"value": -133895000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_investing_activities": {"value": 21800000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_investing_activities_continuing": {"value": 21800000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow": {"value": 213286000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_financing_activities_continuing": {"value": 325381000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}}}}, {"start_date": "2021-07-01", "end_date": "2021-09-30", "filing_date": "2021-11-04", "timeframe": "quarterly", "fiscal_period": "Q3", "fiscal_year": "2021", "cik": "0001743881", "sic": "2834", "tickers": ["BBIO"], "company_name": "BridgeBio Pharma, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-21-003080", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-21-003080/files/bbio-20210930_htm.xml", "financials": {"income_statement": {"participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "income_loss_from_continuing_operations_after_tax": {"value": -161016000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "net_income_loss_available_to_common_stockholders_basic": {"value": -155935000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "income_loss_from_continuing_operations_before_tax": {"value": -161016000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "benefits_costs_expenses": {"value": 163360000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "nonoperating_income_loss": {"value": -11517000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "costs_and_expenses": {"value": 151843000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "research_and_development": {"value": 104305000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "revenues": {"value": 2344000.0, "unit": "USD", "label": "Revenues", "order": 100}, "gross_profit": {"value": 890000, "unit": "USD", "label": "Gross Profit", "order": 800}, "cost_of_revenue": {"value": 1454000.0, "unit": "USD", "label": "Cost Of Revenue", "order": 300}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": -5081000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "interest_expense_operating": {"value": 11067000.0, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}, "selling_general_and_administrative_expenses": {"value": 46084000.0, "unit": "USD", "label": "Selling, General, and Administrative Expenses", "order": 1010}, "income_tax_expense_benefit": {"value": 0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "operating_expenses": {"value": 150389000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "operating_income_loss": {"value": -149499000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "net_income_loss_attributable_to_parent": {"value": -155935000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "net_income_loss": {"value": -161016000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}}, "balance_sheet": {"noncurrent_liabilities": {"value": 1421575000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "wages": {"value": 21560000.0, "unit": "USD", "label": "Wages", "order": 730}, "other_current_liabilities": {"value": 62228000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "current_liabilities": {"value": 95823000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "current_assets": {"value": 639710000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "noncurrent_assets": {"value": 141814000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "liabilities_and_equity": {"value": 781524000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "equity": {"value": -738841000.0, "unit": "USD", "label": "Equity", "order": 1400}, "equity_attributable_to_noncontrolling_interest": {"value": 4556000.0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "other_noncurrent_assets": {"value": 67869000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "assets": {"value": 781524000.0, "unit": "USD", "label": "Assets", "order": 100}, "temporary_equity": {"value": 2967000.0, "unit": "USD", "label": "Temporary Equity", "order": 1700}, "liabilities": {"value": 1517398000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "accounts_payable": {"value": 12035000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "fixed_assets": {"value": 27741000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "equity_attributable_to_parent": {"value": -743397000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "intangible_assets": {"value": 46204000.0, "unit": "USD", "label": "Intangible Assets", "order": 330}}, "cash_flow_statement": {"net_cash_flow_from_financing_activities": {"value": -135456000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_continuing": {"value": -198049000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_investing_activities_continuing": {"value": 58968000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_financing_activities_continuing": {"value": -135456000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow": {"value": -198049000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_investing_activities": {"value": 58968000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_operating_activities": {"value": -121561000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_operating_activities_continuing": {"value": -121561000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_parent": {"value": -155952000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": -5081000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss": {"value": -161033000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "other_comprehensive_income_loss": {"value": -17000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}}}}, {"start_date": "2021-04-01", "end_date": "2021-06-30", "filing_date": "2021-08-05", "timeframe": "quarterly", "fiscal_period": "Q2", "fiscal_year": "2021", "cik": "0001743881", "sic": "2834", "tickers": ["BBIO"], "company_name": "BridgeBio Pharma, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001564590-21-041676", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001564590-21-041676/files/bbio-10q_20210630_htm.xml", "financials": {"cash_flow_statement": {"net_cash_flow_from_operating_activities": {"value": -91713000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow": {"value": -92646000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_financing_activities_continuing": {"value": -1391000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_investing_activities_continuing": {"value": 458000, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_financing_activities": {"value": -1391000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_continuing": {"value": -92646000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_operating_activities_continuing": {"value": -91713000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_investing_activities": {"value": 458000, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}}, "income_statement": {"net_income_loss_attributable_to_parent": {"value": -96348000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "interest_expense_operating": {"value": 10839000.0, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}, "income_loss_from_continuing_operations_before_tax": {"value": -102074000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "selling_general_and_administrative_expenses": {"value": 45970000.0, "unit": "USD", "label": "Selling, General, and Administrative Expenses", "order": 1010}, "operating_expenses": {"value": 147930000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "gross_profit": {"value": 53915000.0, "unit": "USD", "label": "Gross Profit", "order": 800}, "income_tax_expense_benefit": {"value": 0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "revenues": {"value": 54024000.0, "unit": "USD", "label": "Revenues", "order": 100}, "cost_of_revenue": {"value": 109000, "unit": "USD", "label": "Cost Of Revenue", "order": 300}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": -5726000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "benefits_costs_expenses": {"value": 156098000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "operating_income_loss": {"value": -94015000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "costs_and_expenses": {"value": 148039000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "income_loss_from_continuing_operations_after_tax": {"value": -102074000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "research_and_development": {"value": 101960000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "nonoperating_income_loss": {"value": -8059000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "net_income_loss_available_to_common_stockholders_basic": {"value": -96348000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "net_income_loss": {"value": -102074000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}}, "balance_sheet": {"equity_attributable_to_parent": {"value": -464294000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "assets": {"value": 1081486000.0, "unit": "USD", "label": "Assets", "order": 100}, "fixed_assets": {"value": 26272000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "noncurrent_assets": {"value": 171615000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "liabilities": {"value": 1537111000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "equity_attributable_to_noncontrolling_interest": {"value": 6804000.0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "current_assets": {"value": 909871000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "liabilities_and_equity": {"value": 1081486000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "wages": {"value": 21865000.0, "unit": "USD", "label": "Wages", "order": 730}, "accounts_payable": {"value": 22329000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "other_current_liabilities": {"value": 87715000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "temporary_equity": {"value": 1865000.0, "unit": "USD", "label": "Temporary Equity", "order": 1700}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "other_noncurrent_assets": {"value": 145343000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "current_liabilities": {"value": 131909000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "equity": {"value": -457490000.0, "unit": "USD", "label": "Equity", "order": 1400}}, "comprehensive_income": {"comprehensive_income_loss": {"value": -101981000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": -5726000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss_attributable_to_parent": {"value": -96255000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "other_comprehensive_income_loss": {"value": 93000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}}}}, {"start_date": "2021-01-01", "end_date": "2021-03-31", "filing_date": "2021-05-06", "timeframe": "quarterly", "fiscal_period": "Q1", "fiscal_year": "2021", "cik": "0001743881", "sic": "2834", "tickers": ["BBIO"], "company_name": "BridgeBio Pharma, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001564590-21-025064", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001564590-21-025064/files/bbio-10q_20210331_htm.xml", "financials": {"balance_sheet": {"equity_attributable_to_parent": {"value": -395294000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "accounts_payable": {"value": 10340000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "assets": {"value": 1093308000.0, "unit": "USD", "label": "Assets", "order": 100}, "liabilities_and_equity": {"value": 1093308000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "current_liabilities": {"value": 94729000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "equity_attributable_to_noncontrolling_interest": {"value": 5929000.0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "other_current_liabilities": {"value": 63648000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "equity": {"value": -389365000.0, "unit": "USD", "label": "Equity", "order": 1400}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "noncurrent_assets": {"value": 148194000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "wages": {"value": 20741000.0, "unit": "USD", "label": "Wages", "order": 730}, "liabilities": {"value": 1481402000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "other_noncurrent_assets": {"value": 125378000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "temporary_equity": {"value": 1271000.0, "unit": "USD", "label": "Temporary Equity", "order": 1700}, "current_assets": {"value": 945114000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "fixed_assets": {"value": 22816000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}}, "income_statement": {"costs_and_expenses": {"value": 171544000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "net_income_loss": {"value": -171082000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "income_loss_from_continuing_operations_before_tax": {"value": -171082000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "net_income_loss_available_to_common_stockholders_basic": {"value": -163079000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "income_tax_expense_benefit": {"value": 0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": -8003000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "net_income_loss_attributable_to_parent": {"value": -163079000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "cost_of_revenue": {"value": 0, "unit": "USD", "label": "Cost Of Revenue", "order": 300}, "interest_expense_operating": {"value": 9738000.0, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}, "nonoperating_income_loss": {"value": -3578000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "selling_general_and_administrative_expenses": {"value": 45407000.0, "unit": "USD", "label": "Selling, General, and Administrative Expenses", "order": 1010}, "operating_expenses": {"value": 167966000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "gross_profit": {"value": 462000, "unit": "USD", "label": "Gross Profit", "order": 800}, "benefits_costs_expenses": {"value": 171544000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "operating_income_loss": {"value": -167504000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "research_and_development": {"value": 122559000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "revenues": {"value": 462000, "unit": "USD", "label": "Revenues", "order": 100}, "income_loss_from_continuing_operations_after_tax": {"value": -171082000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "other_operating_expenses": {"value": 45407000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}}, "cash_flow_statement": {"net_cash_flow_from_financing_activities_continuing": {"value": 547912000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow": {"value": 115095000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_operating_activities_continuing": {"value": -150765000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_investing_activities_continuing": {"value": -282052000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_operating_activities": {"value": -150765000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_investing_activities": {"value": -282052000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_continuing": {"value": 115095000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_financing_activities": {"value": 547912000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}}, "comprehensive_income": {"comprehensive_income_loss": {"value": -171331000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "other_comprehensive_income_loss": {"value": -249000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": -8003000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss_attributable_to_parent": {"value": -163328000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}}}}, {"start_date": "2020-10-01", "end_date": "2020-12-31", "timeframe": "quarterly", "fiscal_period": "Q4", "fiscal_year": "2020", "cik": "0001743881", "sic": "2834", "tickers": ["BBIO"], "company_name": "BridgeBio Pharma, Inc.", "financials": {"income_statement": {"costs_and_expenses": {"value": -875829000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "revenues": {"value": 122000, "unit": "USD", "label": "Revenues", "order": 100}, "research_and_development": {"value": 90174000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "operating_income_loss": {"value": -127489000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "nonoperating_income_loss": {"value": -7536000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "net_income_loss": {"value": -135025000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "income_loss_from_continuing_operations_before_tax": {"value": 875951000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "benefits_costs_expenses": {"value": -875829000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": -15044000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "income_loss_from_continuing_operations_after_tax": {"value": 875951000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "operating_expenses": {"value": 127611000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "net_income_loss_attributable_to_parent": {"value": -119981000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "interest_expense_operating": {"value": 10962000.0, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}, "net_income_loss_available_to_common_stockholders_basic": {"value": -119981000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "other_operating_expenses": {"value": 37437000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}}, "cash_flow_statement": {"net_cash_flow_from_financing_activities": {"value": 4531000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow": {"value": -8712000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_continuing": {"value": -8712000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_operating_activities": {"value": -96261000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_financing_activities_continuing": {"value": 4531000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_investing_activities_continuing": {"value": 83018000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_operating_activities_continuing": {"value": -96261000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_investing_activities": {"value": 83018000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}}, "balance_sheet": {"equity_attributable_to_noncontrolling_interest": {"value": 48350000.0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "current_liabilities": {"value": 95648000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "temporary_equity": {"value": 1630000.0, "unit": "USD", "label": "Temporary Equity", "order": 1700}, "equity_attributable_to_parent": {"value": 57906000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "other_current_liabilities": {"value": 57021000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "wages": {"value": 29682000.0, "unit": "USD", "label": "Wages", "order": 730}, "accounts_payable": {"value": 8945000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "noncurrent_liabilities": {"value": 500054000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "liabilities": {"value": 595702000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "equity": {"value": 106256000.0, "unit": "USD", "label": "Equity", "order": 1400}, "noncurrent_assets": {"value": 60764000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "current_assets": {"value": 642824000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "assets": {"value": 703588000.0, "unit": "USD", "label": "Assets", "order": 100}, "other_noncurrent_assets": {"value": 40439000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "fixed_assets": {"value": 20325000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "liabilities_and_equity": {"value": 703588000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}}, "comprehensive_income": {"other_comprehensive_income_loss": {"value": -269000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": -15044000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss": {"value": -135294000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_parent": {"value": -120250000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}}}}, {"start_date": "2020-07-01", "end_date": "2020-09-30", "filing_date": "2020-11-05", "timeframe": "quarterly", "fiscal_period": "Q3", "fiscal_year": "2020", "cik": "0001743881", "sic": "2834", "tickers": ["BBIO"], "company_name": "BridgeBio Pharma, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001564590-20-051460", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001564590-20-051460/files/bbio-20200930.xml", "financials": {"comprehensive_income": {"comprehensive_income_loss": {"value": -130564000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "other_comprehensive_income_loss": {"value": -397000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": -14308000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss_attributable_to_parent": {"value": -116256000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}}, "balance_sheet": {"assets": {"value": 787693000.0, "unit": "USD", "label": "Assets", "order": 100}, "equity_attributable_to_parent": {"value": 163756000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "current_liabilities": {"value": 75707000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "fixed_assets": {"value": 16182000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "wages": {"value": 18755000.0, "unit": "USD", "label": "Wages", "order": 730}, "other_noncurrent_assets": {"value": 26127000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "liabilities": {"value": 569306000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "noncurrent_liabilities": {"value": 493599000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "equity": {"value": 215813000.0, "unit": "USD", "label": "Equity", "order": 1400}, "current_assets": {"value": 745384000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "accounts_payable": {"value": 9839000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "liabilities_and_equity": {"value": 787693000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "other_current_liabilities": {"value": 47113000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "noncurrent_assets": {"value": 42309000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "temporary_equity": {"value": 2574000.0, "unit": "USD", "label": "Temporary Equity", "order": 1700}, "equity_attributable_to_noncontrolling_interest": {"value": 52057000.0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}}, "cash_flow_statement": {"net_cash_flow_continuing": {"value": -173952000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_investing_activities_continuing": {"value": -45050000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_operating_activities_continuing": {"value": -131684000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_operating_activities": {"value": -131684000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_investing_activities": {"value": -45050000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_financing_activities_continuing": {"value": 2782000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow": {"value": -173952000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_financing_activities": {"value": 2782000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}}, "income_statement": {"net_income_loss": {"value": -130167000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "interest_expense_operating": {"value": 10929000.0, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}, "operating_expenses": {"value": 128066000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "net_income_loss_attributable_to_parent": {"value": -115859000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "income_loss_from_continuing_operations_before_tax": {"value": -130167000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "net_income_loss_attributable_to_nonredeemable_noncontrolling_interest": {"value": -13177000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Nonredeemable Noncontrolling Interest", "order": 3400}, "revenues": {"value": 8127000.0, "unit": "USD", "label": "Revenues", "order": 100}, "research_and_development": {"value": 92050000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "net_income_loss_available_to_common_stockholders_basic": {"value": -115859000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "nonoperating_income_loss": {"value": -10228000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "operating_income_loss": {"value": -119939000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": -14308000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "costs_and_expenses": {"value": 138294000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "income_loss_from_continuing_operations_after_tax": {"value": -130167000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "benefits_costs_expenses": {"value": 138294000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "other_operating_expenses": {"value": 36016000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}}}}]